 |
|
Scripps Research Scientists Discover Remarkable Editing System For Protein Production
January 03, 2008Even small mistakes made by cells during protein production can have profound disease effects, but the processes cells use to correct mistakes have been challenging to decipher. Recent work by scientists at The Scripps Research Institute, however, has uncovered two surprising new methods for such editing.
The work, published in the January 3, 2008 issue of the journal Nature, and led by Professor Paul Schimmel of the Skaggs Institute for Chemical Biology at Scripps Research, could help identify underlying causes of a range of diseases and, in time, even ways to correct the errors.
Producing proteins is an essential but complicated process involving a number of components. Messenger RNA within cells act as the instructions for protein synthesis. Ribosomes are cellular structures that read these instructions and follow their directions to bind with bits of transfer RNA carrying the amino acids needed for a given protein chain. In most cases, a single unique form of transfer RNA binds only to a single amino acid, and a specific enzyme called a synthetase is responsible for joining the two.
In very rare cases-typically a fraction of a percent-transfer RNA binds with the wrong amino acid. If this error, or mistranslation, is not corrected, that mistranslated amino acid is ultimately incorporated into a protein. Past research by the Schimmel team and others has shown that as little as one wrong amino acid can have profound consequences for health.
"Even such a tiny defect can overwhelm a cell's ability to deal with misfolded proteins, ultimately causing specific neurological problems," says Scripps Research molecular biologist Kirk Beebe, first author of the new paper with Marissa Mock.
Quality Control
The prevailing thinking among researchers in the field has been that the portions of synthetases that recognize and bind transfer RNA and appropriate amino acids are so accurate that little editing is required. What little editing does occur was thought tied to the same checkpoints within the enzymes that perform recognition and binding.
But the current study suggests a new perspective is needed, at least for one widely studied enzyme, a synthetase found in everything from bacteria to humans that binds the amino acid alanine.
The Schimmel team's research revealed that a completely distinct segment of the enzyme acts as a second checkpoint responsible for identifying mistranslations and removing any amino acid besides alanine that might attach to the alanine transfer RNA. Remarkably, this second zone within the enzyme focuses its activity on the very same two nucleotides in the genetic code of the transfer RNA used by the first checkpoint, a guanine and uracil pair referred to as G3•U70.
"The part that is astonishing is that the information that each of these checkpoints is looking for is embedded in the same transfer RNA molecule," says Schimmel, "There's no precedent for this that we're aware of."
The researchers were able to show that this editor checkpoint, even when separated from the rest of the enzyme, was able to efficiently cleave mistranslated amino acids from the alanine transfer RNA. Further experiments revealed that when the G3•U70 pair was transferred to a different type of transfer RNA, the editing unit still removed a non-alanine amino acid, showing clearly that the pair is the trigger for the activity.
Mystery Solved?
The research also led to a surprising find regarding segments of genome-encoded fragments common in cells and sometimes referred to as freestanding domains, whose functions have been debated for many years. The team found that certain freestanding domains with a genetic sequence very similar to the second checkpoint in the alanine synthetase can independently remove mistranslated amino acids in test tube experiments. This suggests that the fragments may act as yet another checkpoint to ensure that proteins are properly synthesized. The activity by the freestanding domain, called AlaXp, also targets the G3•U70 pair.
Whether AlaXp actually edits within cells is not certain, and how they could perform such a function is also not yet clear. "That's still a question to be resolved," says Beebe, "But our work presents a great possibility for how things are likely to occur." The group has already begun new experiments to study AlaXp activity in mouse cells.
"The results of the study were a complete surprise to us," says Schimmel.
Beebe and Schimmel agree that the apparent triple redundancy the team discovered for preventing mistranslation highlights the importance of accurate protein synthesis. It is unlikely such a robustly redundant system would have evolved, they say, if this were not the case.
The work's impact should go beyond adding to the limited understanding of how cells avoid errors during protein synthesis. "We do think there are probably powerful connections to disease," says Schimmel.
Schimmel's and other groups have already shown clear connections between individual and cumulative errors in translation and a variety of problems tied to aging, such as neurodegenerative conditions. Now the Schimmel team has begun collaborative work with a number of other research groups to identify in synthetases telltale genetic mutations referred to as small nucleotide polymorphisms that can lead to mistranslation. Identifying such errors could reveal the underlying causes of diseases currently not understood and possibly identify potential paths for treatment.
In addition to Beebe, Mock, and Schimmel, Eve Merriman was an author on the new Nature paper, entitled "Distinct domains of tRNA synthetase recognize the same base pair." All authors are from The Scripps Research Institute.
The study was funded by the National Institutes of Health, the Skaggs Foundation, and the National Foundation for Cancer Research.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, genetics, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, cancer biology, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.
Scripps Research Institute
In very rare cases-typically a fraction of a percent-transfer RNA binds with the wrong amino acid. If this error, or mistranslation, is not corrected, that mistranslated amino acid is ultimately incorporated into a protein. Past research by the Schimmel team and others has shown that as little as one wrong amino acid can have profound consequences for health.
"Even such a tiny defect can overwhelm a cell's ability to deal with misfolded proteins, ultimately causing specific neurological problems," says Scripps Research molecular biologist Kirk Beebe, first author of the new paper with Marissa Mock.
Quality Control
The prevailing thinking among researchers in the field has been that the portions of synthetases that recognize and bind transfer RNA and appropriate amino acids are so accurate that little editing is required. What little editing does occur was thought tied to the same checkpoints within the enzymes that perform recognition and binding.
But the current study suggests a new perspective is needed, at least for one widely studied enzyme, a synthetase found in everything from bacteria to humans that binds the amino acid alanine.
The Schimmel team's research revealed that a completely distinct segment of the enzyme acts as a second checkpoint responsible for identifying mistranslations and removing any amino acid besides alanine that might attach to the alanine transfer RNA. Remarkably, this second zone within the enzyme focuses its activity on the very same two nucleotides in the genetic code of the transfer RNA used by the first checkpoint, a guanine and uracil pair referred to as G3•U70.
"The part that is astonishing is that the information that each of these checkpoints is looking for is embedded in the same transfer RNA molecule," says Schimmel, "There's no precedent for this that we're aware of."
The researchers were able to show that this editor checkpoint, even when separated from the rest of the enzyme, was able to efficiently cleave mistranslated amino acids from the alanine transfer RNA. Further experiments revealed that when the G3•U70 pair was transferred to a different type of transfer RNA, the editing unit still removed a non-alanine amino acid, showing clearly that the pair is the trigger for the activity.
Mystery Solved?
The research also led to a surprising find regarding segments of genome-encoded fragments common in cells and sometimes referred to as freestanding domains, whose functions have been debated for many years. The team found that certain freestanding domains with a genetic sequence very similar to the second checkpoint in the alanine synthetase can independently remove mistranslated amino acids in test tube experiments. This suggests that the fragments may act as yet another checkpoint to ensure that proteins are properly synthesized. The activity by the freestanding domain, called AlaXp, also targets the G3•U70 pair.
Whether AlaXp actually edits within cells is not certain, and how they could perform such a function is also not yet clear. "That's still a question to be resolved," says Beebe, "But our work presents a great possibility for how things are likely to occur." The group has already begun new experiments to study AlaXp activity in mouse cells.
"The results of the study were a complete surprise to us," says Schimmel.
Beebe and Schimmel agree that the apparent triple redundancy the team discovered for preventing mistranslation highlights the importance of accurate protein synthesis. It is unlikely such a robustly redundant system would have evolved, they say, if this were not the case.
The work's impact should go beyond adding to the limited understanding of how cells avoid errors during protein synthesis. "We do think there are probably powerful connections to disease," says Schimmel.
Schimmel's and other groups have already shown clear connections between individual and cumulative errors in translation and a variety of problems tied to aging, such as neurodegenerative conditions. Now the Schimmel team has begun collaborative work with a number of other research groups to identify in synthetases telltale genetic mutations referred to as small nucleotide polymorphisms that can lead to mistranslation. Identifying such errors could reveal the underlying causes of diseases currently not understood and possibly identify potential paths for treatment.
In addition to Beebe, Mock, and Schimmel, Eve Merriman was an author on the new Nature paper, entitled "Distinct domains of tRNA synthetase recognize the same base pair." All authors are from The Scripps Research Institute.
The study was funded by the National Institutes of Health, the Skaggs Foundation, and the National Foundation for Cancer Research.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, genetics, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, cancer biology, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.
Scripps Research Institute
Amino Acid Current Events and Amino Acid News RSSStudy sheds light on causes of HIV dementia
A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications.
Selenium may slow march of AIDS
Increasing the production of naturally occurring proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists.
Glowing Results-Pitt Researchers Use Fluorescence to Develop Fast, Simple Method for Detecting Mercury in Fish and Dental Fillings
Researchers at the University of Pittsburgh have developed a simple and quick method for detecting mercury in fish and dental samples, two substances at the center of public concern about mercury contamination.
Scientists map steps to block key enzyme action in heart failure
Taking a cue from the way drugs like Viagra put the biological brakes on a key enzyme involved in heart failure, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking the enzyme.
UC Davis researchers discover Achilles' heel in pancreatic cancer
UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.
Sensitive laser instrument could aid search for life on Mars
Minuscule traces of cells can be detected in a mineral likely present on Mars, a new study shows. The results, obtained using a technique developed at the U.S. Department of Energy's Idaho National Laboratory, could help mission scientists choose Martian surface samples with the most promise for yielding signs of life.
Vitamin B does not slow cognitive decline in Alzheimer's
A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease.
The Structure of the Mre11 Protein Bound to DNA
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
MU scientists 'see' how HIV matures into an infection
After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature.
Study confirms benefit of combination therapy for Alzheimer's disease
Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities.
More Amino Acid Current Events and Amino Acid News Articles
 | Amino Acids in Therapy: A Guide to the Therapeutic Application of Protein Constituents by Leon Chaitow This comprehensive guide for health practitioners covers all aspects of amino acid therapy and lists conditions which are particularly responsive to such treatment. Includes information on:     Amino acid profiles     Why individual requirements differ      Amino acids and protein     Amino acids and the body cycles      Disorders of amino acid... |
| Heal With Amino Acids and Nutrients: Survive Stress, Pain, Anxiety, Depression Without Drugs, What to Use and When by Billie Jay Sahley, Katherine M. Birkner | |
 | Amino Revolution by Robert Erdmann |
 | Heal with Amino Acids and Nutrients by PhD, CNC Billie J. Sahley Most recent edition of Heal with Amino Acids! Amino Acids are the medicines of the 21st century. Your brain and body cannot function without amino acids. Heal with Amino Acids: -- Updated and Expanded to 244 pages -- Drugs DO NOT make Neurotransmitters! Amino Acids Do!Learn the natural power of amino acids to: Control the anxiety "stop switch." Enhance brain function, memory, and... |
 | Amino Acid Derivatives: A Practical Approach (Practical Approach Series) Amino acids are increasingly becoming the first compound that chemists turn to when planning a synthesis leading to a homochiral target. Much of this activity is centered around peptide synthesis, however there is a very wide and demanding range of chemistry that describes the synthesis of derivatives of the a-amino acids and some uses of those derivatives that do not involve peptides. This book... |
 | Protein and Amino Acid Requirements in Human Nutrition (Technical Report Series) by World Health Orgqanization The World Health Organization and the Food and Agriculture Organization have worked to quantify the energy and nutrient needs of populations since 1949. This is the latest in a series of reports that aim to provide updates on protein and amino acid requirements in health and disease for all age groups and pregnant and lactating mothers; recommendations on protein requirements in health and... |
 | The Healing Nutrients Within: Facts, Findings, and New Research on Amino Acids by Eric R. Braverman The two dozen amino acids present in the human body are now being shown to be among the most potent healing substances ever discovered. These constituents of protein are necessary to everyday life processes, but rsearch and clinical work in the last two decades have revealed a vast range of therapeutic functions for amino acids, including phenyhlalanine's pain-relieving powers, tyrosine's... |
 | Amino Acids and Proteins for the Athlete: The Anabolic Edge, Second Edition (Nutrition in Exercise & Sport) by Mauro G. Di Pasquale Extensively updated with double the information and references, this second editionadvises the athlete on how to use amino acids and proteins to enhance performance. It reveals the actions of protein and amino acid supplements on muscle size and strength and energy metabolism as well as the role of specific amino acid supplements. Written by twelve-time powerlifting champion and physician Mauro... |
| Biocatalytic Production of Amino Acids and Derivatives (Biotechnology) This book describes the principles and methods, many recently developed, used in the commercial production of amino acids and biocatalysts. The text features discussion of new technology being used for the development of membrane reactors, the use of enzymes in nonaqueous solvents, and the application of recombinant DNA techniques for cloning and gene expression. Also covered are newly... | |
 | User's Guide to Protein and Amino Acids (Basic Health Publications User's Guide) by Keri Marshall In the post-Atkins world of nutrition and diet, protein has become one of the most misunderstood nutrients. Essential for health, protein in your diet is broken down during digestion and later restrctured to make the proteins and enzymes your body needs for life. For example, protein stabilizes blood sugar levels and protects against diabetes. Protein itself consists of building blocks called... |
| © 2008 BrightSurf.com |